BindingDB logo
myBDB logout

27 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26710088 248 Recent Progress in Histone Demethylase Inhibitors.EBI University of Oxford
26985284 30 Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.EBI Therachem Research Medilab (India) Pvt. Ltd.
26771107 113 Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.EBI GlaxoSmithKline R&D
26699912 108 Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.EBI University of Oxford
26771203 114 Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.EBI GlaxoSmithKline R&D
26101571 45 Identification of Jumonji AT-Rich Interactive Domain 1A Inhibitors and Their Effect on Cancer Cells.EBI Kyoto Prefectural University of Medicine
23964788 56 Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity.EBI Kyoto Prefectural University of Medicine
22975593 62 Oncoepigenomics: making histone lysine methylation count.EBI TBA
22917519 106 Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).EBI University of Copenhagen
21955276 60 Lysine demethylases inhibitors.EBI Kyoto Prefectural University of Medicine
20684604 46 Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors.EBI Nagoya City University
 12 Calorimetric Studies on the Complexation of Several Ferrocene Derivatives by .alpha.- and .beta.-Cyclodextrin. Effects of Urea on the Thermodynamic ParametersBDB University of Miami
19237286 30 Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.BDB GSK
19217287 30 Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.BDB Abbott Laboratories
19260677 11 Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.BDB Toronto General Research Institute
18054488 24 Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.BDB Vertex Pharmaceuticals
18640037 48 Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.BDB Universita degli Studi di Firenze
18729351 21 Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.BDB University of Queensland
 8 AR-709-An Investigational diaminopyrimidine: Inhibition, Binding and Mode of Action.BDB ARPIDA AG
16931004 29 Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.BDB GlaxoSmithKline
14998327 12 Structure-based optimization of novel azepane derivatives as PKB inhibitors.BDB Roche Diagnostics GmbH
11708928 17 Role of hydrophilic interaction in binding of hydroxylated 3-deoxy C(19) steroids to the active site of aromatase.BDB Tohoku Pharmaceutical University
28841282 2 Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors.BDB Istituto Italiano di Tecnologia